Cargando…
Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
BACKGROUND: Canine pancreatic carcinoma is a rare, aggressive tumour that is often diagnosed late in the course of disease. Effective treatment strategies have been elusive, and overall survival time is short. In humans, treatment with tyrosine kinase inhibitors alone, or in combination with IV gemc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356392/ https://www.ncbi.nlm.nih.gov/pubmed/34380474 http://dx.doi.org/10.1186/s12917-021-02978-8 |